EDAP TMS reported EUR37.48M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
AngioDynamics USD 41.57M 127K Sep/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
EDAP TMS EUR 37.48M 90K Mar/2026
Henry Schein USD 110.54M 1.38M Sep/2026
Medtronic USD 1.28B 130K Jun/2026
Plus Therapeutics USD 275K 138.4M Mar/2026
Veracyte USD 80.39M 598K Sep/2026